Highlights
KLSE: DPHARMA (7148)       DUOPHARMA BIOTECH BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
1.35   +0.01 (0.75%)  1.34 - 1.36  81,400
Analyze this stock with MQ Trader system

Price Target

Date Open Price Target Price Upside/Downside Price Call Source
06/09/2019 1.41 1.70 +0.29 (20.57%) BUY TA
03/09/2019 1.41 1.62 +0.21 (14.89%) BUY TA
23/05/2019 1.36 1.62 +0.26 (19.12%) BUY TA
22/03/2019 1.20 1.61 +0.41 (34.17%) BUY TA

View Price Target Detail
Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more.

  4 people like this.
 
yapchehhak Slow and steady win the race
29/03/2019 7:31 AM
chshzhd good counter,keep for long term..
29/03/2019 12:35 PM
Manekineko Agree, waiting for next entry point when drop.
03/04/2019 4:38 PM
Dakewlest Any idea for next entry point?
04/04/2019 10:30 AM
Dakewlest Anyone know when are we getting the 4sen dividend?
08/04/2019 10:34 AM
chshzhd last year div ex june
08/04/2019 11:05 AM
VSOLAR Sailang Margin All In Punter thinking this counter not bad too
08/04/2019 9:35 PM
Dakewlest I bought some this week... may add some more later.
10/04/2019 3:50 PM
Investeye Disposed some to take profit..
10/04/2019 4:54 PM
Investeye Disposed most of the lots as EPF is gradually disposed this counter..
Wait for next wave..
23/04/2019 9:56 AM
Dakewlest Epf acquired last week.
23/04/2019 12:28 PM
Investeye Disposed all DPharma and bank on Pharma. In general, EPF disposed more than acquired..
23/04/2019 4:40 PM
keyin Why EPF do so
23/04/2019 5:37 PM
VinLol123 This counter suitable for long term..
27/04/2019 3:31 PM
YAPSS Day 81 of Fundamental Daily, YAPSS will be covering Duopharma Biotech Berhad's fundamental via a short animated video. I hope it helps and please enjoy the video, see ya! #YAPSS #FundamentalDaily #DuopharmaBiotechBerhad

Click the on the link to find out more: https://youtu.be/wKtLhzvZy_c
25/05/2019 9:28 AM
moneytrail Going for DRP and hold long term! Healthy sales!
22/06/2019 6:39 PM
factorrumour price has been flat for quite some time already, is it a good time to enter?
25/06/2019 4:08 PM
Ern Siah How to do the reinvestment?
26/06/2019 12:41 AM
NewbieTradingChannel Dpharma 7/7/2019 now it is on a symmetrical triangle ... breaking 1.3900 can target 1.440.
07/07/2019 1:25 PM
Jason bullish engulfing with volume, show time?
01/08/2019 4:22 PM
k3nthiew https://www.reuters.com/article/us-duopharma-btech-malaysia/malaysias-duopharma-talks-deals-with-trade-war-hit-chinese-firms-idUSKCN1UW0E4
06/08/2019 4:11 PM
k3nthiew KUALA LUMPUR (Reuters) - Duopharma Biotech (DUOP.KL), Malaysia’s largest generic drugmaker, is in talks with two Chinese consumer healthcare companies for expansion of their production base in Southeast Asia and a potential stake sale, its managing director said.

During an interview with Reuters, Duopharma Managing Director Leonard Ariff bin Abdul Shatar declined to name the companies as the discussions were ongoing. However, he said both “reasonably big” companies were listed in China with an annual revenue of more than $1 billion each.

The Chinese companies, one based in Shanghai and the other in Beijing, had asked Kuala Lumpur’s Duopharma if it would be able to contract-manufacture for them. They have also discussed buying a stake in Duopharma, Leonard said.

“They have manufacturing bases currently in China, supplying to the United States. These are guys whom I would not have expected to see in this part of the world, but for the trade war,” he said.

Duopharma, which has a market valuation of about $220 million, was open to a stake sale of up to 10% in the company, Leonard said, adding that if a deal was finalised, the Malaysian firm will apply to register with the U.S. Food and Drug Administration.

“There is a famous Malay saying: when two elephants fight, the ants die. But what we see here is absolutely the opposite. This has come as a bit of a surprise,” he said.

Dented by higher U.S. tariffs, Chinese companies are seeking partners to partly shift their supply chain to Southeast Asian countries such as Vietnam, Malaysia and Indonesia, analysts and Malaysian government officials said.

In the first quarter of 2019, Southeast Asia’s third-biggest economy attracted foreign investment of more than $7 billion – a 73% surge from a year earlier. The Malaysian government and its trade agencies are sending their representatives to China and other countries, organizing seminars and signing agreements of cooperation.

Late last month, the China ambassador to Malaysia confirmed the high level of Chinese interest in its traditional trade partner.
06/08/2019 4:12 PM
Coldman Very good news for stakeholder, hope it can be deal soon.
06/08/2019 4:50 PM
Jason Good fundamental and aggressive management. This counter is worth to hold for long term investment.
06/08/2019 5:20 PM
moneytrail No action yet. So difficult to bull doze pass 1.43. :(
07/08/2019 11:04 PM
Jason 1.43 been tested many times. Damn hard to breach.
08/08/2019 9:36 AM
Shootup what so good it is, gotta share profit out after the deal
09/08/2019 6:19 AM
Jason what happens to dpharma today?
21/08/2019 5:07 PM
kalofarmako Hello
22/08/2019 3:37 PM
Jason hope it can break the strong resistance at 1.43.
22/08/2019 4:25 PM
factorrumour only super good quarter result can help it push to all time high and new record
23/08/2019 12:07 AM
Jason finally it moves after consolidate for so long
23/08/2019 2:56 PM
Shootup All time high qr must be good
23/08/2019 3:14 PM
kalofarmako yeahh. i can see the movement there.
26/08/2019 10:45 AM
kalofarmako It's going up time to buy ! Come on gaiss.

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/221505.jsp
26/08/2019 10:52 AM
Jason quiet counter
27/08/2019 11:12 PM
kalofarmako Quiet but the price still okay hoo
28/08/2019 9:55 AM
kalofarmako Pharmaniaga’s focus on non-concession ops seen to boost profit

https://www.klsescreener.com/v2/news/view/572140
28/08/2019 9:59 AM
Jason among all the other healthcare counter, only this one is on uptrend. Phamaniage revenue and profit is inconsistent and poor cash flow, no way to compare to duopharma.
28/08/2019 11:54 AM
Jason dpharma rock today, achieving new high..
29/08/2019 4:07 PM
kalofarmako Morning!

Something good to read in the morning.

"High time to decide on concession issue"

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/222426.jsp
30/08/2019 9:10 AM
Jason boring dpharma
03/09/2019 9:00 PM
kalofarmako WOW!!

The positive long-term outlook for Pharmaniaga

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/223457.jsp
05/09/2019 1:09 PM
kalofarmako DHM explained that Pharmaniaga is only responsible for the logistics of supplying drugs to government health facilities, rather than the supply itself.

Check out here: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224313.jsp
11/09/2019 10:56 AM
rajachulan I had stopped buying any stock which dealing with gomen... many months ago... after i have seen how gomen play construction sector...

gdluck buying stock dealing with gomen...
11/09/2019 11:00 AM
kalofarmako “The big problem is price control, not Pharmaniaga,” says MyCC

Social activist Lim Mah Hui, one of the conductors of the MyCC study, said Pharmaniaga did not have a monopoly over supply but a virtual monopoly over logistics.

Check out: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224759.jsp
13/09/2019 9:52 AM
rajachulan no doubt... healthcare and insurance are two industries APAC to grow next few decade... however... if the govt !@#$%^&*()... then !@#$%^&*()
13/09/2019 10:07 AM
Jason drop like hell, this counter really need super long term investment
17/09/2019 2:01 PM
chshzhd buy..
17/09/2019 4:40 PM
Jason volume coming in this few days, many people is accumulating
18/09/2019 5:51 PM


 

218  266  536  1305 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MNC-PA 0.045+0.005 
 ARMADA 0.325+0.01 
 GPACKET-WB 0.2650.00 
 HSI-C7J 0.22-0.03 
 SAPNRG 0.28-0.01 
 KNM 0.405+0.01 
 HSI-C7F 0.40-0.055 
 VSOLAR 0.0950.00 
 MNC 0.115+0.005 
 HSI-H6S 0.19+0.035 

TOP ARTICLES

1. Dayang: Investors' Dilemma - Koon Yew Yin Koon Yew Yin's Blog
2. KNM: A relook into KNM from Profitability, Volume Spread Analysis and what’s Insiders Report are telling they are doing now ? TradeVSA - Case Study
3. OPCOM (0035) OPTIMAL OPTIC COMPANY : THE SUPER-STOCK OF THE DIGITAL ECONOMY, Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
4. What is the thing happen with Boustead and how do we capture the oppurtunity Stevent Hee
5. [转贴] 马云最失败的投资?上百亿打造的无人超市,如今变成怎样? Good Articles to Share
6. KNM Break Up : Time for the Long Awaited Rally 128Huat Potential StockPick
7. PublicInvest Research Headlines - 19 Sept 2019 PublicInvest Research
8. [12Invest] 壹贰讲股 - 浅谈冷门油气股 Deleum Berhad(5132) [12Invest] - 壹贰讲股
Partners & Brokers